--- title: "12 Health Care Stocks Moving In Wednesday's After-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/295712931.md" description: "During Wednesday's after-market session, several healthcare stocks experienced significant volatility. Gainers included ENvue Medical (up 49.1%), Omeros (up 22.46%), and Bone Biologics (up 13.2%). Conversely, Outlook Therapeutics fell 16.2%, while Valion Bio dropped 14.61%. These movements were largely driven by the release of Q2 earnings reports for companies such as Omeros, RenovoRx, and MaxCyte." datetime: "2026-08-12T21:06:17.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295712931.md) - [en](https://longbridge.com/en/news/295712931.md) - [zh-HK](https://longbridge.com/zh-HK/news/295712931.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Wednesday's After-Market Session ### Gainers - **ENvue Medical** (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market session. The market value of their outstanding shares is at $2.4 million. - **Omeros** (NASDAQ:OMER) stock moved upwards by 22.46% to $16.79. The company's market cap stands at $984.3 million. As per the news, the Q2 earnings report came out today. - **Bone Biologics** (NASDAQ:BBLG) stock increased by 13.2% to $0.74. The company's market cap stands at $1.6 million. - **Biote** (NASDAQ:BTMD) stock rose 9.85% to $1.56. The market value of their outstanding shares is at $46.7 million. - **Redhill Biopharma** (NASDAQ:RDHL) stock moved upwards by 8.32% to $0.64. The company's market cap stands at $3.6 million. - **RenovoRx** (NASDAQ:RNXT) stock moved upwards by 7.14% to $1.2. The company's market cap stands at $51.8 million. As per the press release, Q2 earnings came out today. ### Losers - **Outlook Therapeutics** (NASDAQ:OTLK) shares fell 16.2% to $0.92 during Wednesday's after-market session. The company's market cap stands at $211.3 million. - **Valion Bio** (NASDAQ:VBIO) stock fell 14.61% to $0.19. The market value of their outstanding shares is at $1.2 million. - **Modular Medical** (NASDAQ:MODD) stock decreased by 13.05% to $1.8. The company's market cap stands at $10.9 million. - **AngioDynamics** (NASDAQ:ANGO) shares fell 11.37% to $13.96. The market value of their outstanding shares is at $650.9 million. - **Curis** (NASDAQ:CRIS) stock decreased by 10.78% to $1.49. The market value of their outstanding shares is at $4.8 million. - **MaxCyte** (NASDAQ:MXCT) stock fell 9.46% to $1.15. The market value of their outstanding shares is at $132.8 million. The company's, Q2 earnings came out today. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [VBIO.US](https://longbridge.com/en/quote/VBIO.US.md) - [OTLK.US](https://longbridge.com/en/quote/OTLK.US.md) - [FEED.US](https://longbridge.com/en/quote/FEED.US.md) - [BBLG.US](https://longbridge.com/en/quote/BBLG.US.md) - [OMER.US](https://longbridge.com/en/quote/OMER.US.md) - [RNXT.US](https://longbridge.com/en/quote/RNXT.US.md) - [MXCT.US](https://longbridge.com/en/quote/MXCT.US.md) - [BTMD.US](https://longbridge.com/en/quote/BTMD.US.md) - [RDHL.US](https://longbridge.com/en/quote/RDHL.US.md) - [MODD.US](https://longbridge.com/en/quote/MODD.US.md) - [ANGO.US](https://longbridge.com/en/quote/ANGO.US.md) - [CRIS.US](https://longbridge.com/en/quote/CRIS.US.md) - [BBLGW.US](https://longbridge.com/en/quote/BBLGW.US.md) ## Related News & Research - [Outlook Therapeutics posts CEO Bob Jahr “Why Now” investor conference webcast on demand](https://longbridge.com/en/news/297190965.md) - [Omeros VP Finance, CAO David J. Borges reports disposal of common shares worth $206,935.60](https://longbridge.com/en/news/297012425.md) - [RenovoRx highlights Phase III TIGeR-PaC sub-study showing 51% tumor-site gemcitabine extraction with TAMP delivery](https://longbridge.com/en/news/296914646.md) - [Insider Shake-Up at Omeros as Key Director Sells Off a Chunk of Shares](https://longbridge.com/en/news/296662749.md) - [Omeros director Joseph L. Schocken files initial beneficial ownership statement](https://longbridge.com/en/news/296288452.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**